Opportunities

Challenge for early-stage entrepreneurs developing science-driven technologies for healthy aging or aging-related conditions. Up to 21 finalists receive a $24,000 prize and a five-month accelerator; seven winning teams may receive an additional $70,000 prize.

Recurring grant program for independent early-career faculty pursuing basic mechanisms of aging and aging-process links to age-related conditions.

Funding for a coordinating center that will integrate and disseminate multi-omic, epigenomic, spatial, neuropathological, and connectomic mouse-brain datasets spanning normal aging and Alzheimer's disease.

Support for hypothesis-driven research on fundamental epigenetic mechanisms and their relevance to healthy aging, including chromatin regulation, DNA methylation, cellular identity, and postnatal stem and progenitor cell states.

Multi-center pilot program for research relevant to aging or age-associated disease, built around complementary Nathan Shock Center resources for aging-gene discovery. Postdoctoral applicants may apply as co-investigators with a mentor or with an independence and mentorship letter.

Open-topic canine-health research cycle accepting Acorn and Oak proposals, including eligible studies of canine aging, age-related disease mechanisms, stem-cell approaches, diagnostics, and interventions that directly benefit dog health.

Bridge funding for a well-reviewed dementia-research proposal that was not funded by its original funder, including mechanistic work on neurodegeneration and protein pathology when aligned with Alzheimer Nederland's research agenda.

Personal grant for a new national or international collaboration or practical placement that broadens a promising researcher's knowledge, experience, and skills for more impactful dementia research.

Travel and subsistence support for a research internship abroad of at least two months, enabling researchers and master's students to gain skills for a scientific career in dementia research.

Short-duration bridge support for early-career-led Alzheimer's, Parkinson's, frontotemporal dementia, Lewy-body dementia, atypical Parkinson's, and related neurodegeneration projects disrupted by specified changes in U.S. federal research funding.

Recurring intensive training program for emerging researchers that covers aging biology and other aging-research fields, research methods, interventions, career development, and NIA grant preparation.

Funding for completion of a phase 1, 2, or 3 interventional clinical trial of a stem-cell-based or genetic therapy addressing a significant unmet medical need. Projects may run for up to four years.

Institutional funding to add stem-cell biology, gene therapy, and regenerative-medicine coursework and paid research internships to California certificate, undergraduate, and master's training pathways.

Spring 2026 pilot awards for developing or validating measures of healthy aging, including biochemical assays, composite indices, physical and cognitive performance measures, survey instruments, and biospecimen or data-collection methods.

Rolling letters of inquiry for foundational, translational, drug-discovery, and preclinical or clinical Alzheimer's research, including genetics, biomarkers, epigenetics, protein pathology, immunity, and alternative neurodegenerative pathways.

Nomination-based awards recognizing US graduate students with research records and leadership promise in geroscience, biology of aging, or related disciplines.

One-to-two-year international mobility fellowships for biological research, usable for mechanistic projects on aging hallmarks such as autophagy, proteostasis, mitochondrial quality, genome stability, or cellular senescence.

Two- to three-year fellowship with rotations across FDA centers and a non-laboratory regulatory-science project concerning cell therapy, gene therapy, tissue-engineered products, or other regenerative-medicine products.

Up to twelve months in a foreign academic laboratory for France-based investigators to learn new methods, develop new approaches, and establish collaborations in Alzheimer's disease and related disorders.

Grant program for established investigators proposing pioneering research into biological mechanisms of normal human aging, physiological decline, and translational discoveries relevant to healthspan.

Postdoctoral fellowship program supporting research on basic aging mechanisms and translational findings with direct relevance to human aging and healthspan.

Two-year R03 support for early-career clinician-scientists in medical, surgical, dental, and other clinical specialties to conduct a first independent project that integrates aging or geriatrics with their specialty. Projects may be basic, translational, clinical, genetic, or epidemiologic.

Research award program for independent investigators pursuing transformative clinical-translational or basic biological studies of cognitive aging and age-related memory loss.

Short-term mentored training program that places medical students in basic, translational, clinical, or health-services research related to aging and geriatrics.

$5,000 to $20,000 in Minnesota Nathan Shock Center core services for geroscience pilots. Core capabilities include DNA damage and epigenetics, DNA-damage signaling and nucleotide-excision repair, and models of genome instability, senescence, and aging.

Upcoming open-topic canine-health call covering Established Investigator, First Award, Pilot Study, and Fellowship Training mechanisms; canine aging and age-related mechanism studies may apply when framed around dog health.

Recurring opportunity to nominate pharmacological interventions for robust lifespan and healthspan testing across genetically diverse Caenorhabditis species and strains.

Institutional R25 support for intensive postbaccalaureate research experiences that prepare recent graduates for advanced study or private-sector research careers in Alzheimer's disease and related dementias.

Institutional R25 support for intensive summer Alzheimer's disease and related dementias research experiences for high-school students, undergraduates, or science teachers.

Recurring peer-reviewed opportunity to propose agents for standardized testing of effects on lifespan and healthspan in genetically heterogeneous mice.

Three-to-five-year mentored career development support for investigators pursuing research independence in biomedical, behavioral, or clinical aging and dementia research.

Institutional T32 support for U.S.-based predoctoral and postdoctoral research-training programs across all areas of aging research. Programs combine mentored research, didactic training, and career development and may be funded for up to five years.

Phased support for bundled Phase 1 and Phase 1b/2a trials of small molecules or biologics engaging non-amyloid and non-tau mechanisms across the Alzheimer's disease and related dementias spectrum.

One-year pilot support for basic or translational aging research, including senescence, mitochondrial dysfunction, proteostasis, epigenetic alterations, nutrient sensing, inflammation, biomarkers, and healthspan interventions.

Rolling funding for decision-enabling preclinical or clinical development of Parkinson's therapies, including programs directed at mitochondrial dysfunction, lysosomal clearance, autophagy, and pathological protein handling.

Two-year support for high-risk foundational or translational Parkinson's research, including cellular and molecular mechanisms, therapeutic targets and candidates, biomarkers, and preclinical proof-of-concept studies.

Two-year international fellowships for mentored research that directly advances understanding or treatment of Parkinson's disease across basic, translational, and clinical research.

Funding for early human clinical studies of novel or repurposed potential medicines for Alzheimer's disease and related dementias, including approaches directed at protein aggregation, cellular clearance, mitochondrial biology, or other supported disease mechanisms.

Career-development award for clinically trained early-stage investigators with leadership potential in research intended to improve health outcomes for older people.

Recurring award for junior faculty conducting aging-related genomics, epigenomics, transcriptomics, proteomics, metabolomics, methylomics, comparative omics, or intervention-focused omics research.

Three-year bridge support for inventive clinical, preclinical, or basic Parkinson's research by early-career faculty, including studies of disease mechanisms and treatment approaches.

$1,000 to $10,000 for small projects focused on mechanistic hallmarks or energetics of aging, intended to generate critical data for an upcoming grant submission and use UAB Nathan Shock Center research cores.

The 2026 cycle offered a one-year graduate-student award up to $25,000, a two-year postdoctoral fellowship up to $50,000, and a two-year principal-investigator award up to $100,000 for primary mitochondrial disease research.

Mentor-guided mitochondrial-medicine training for residents or fellows who remain at their current institutions, including protected clinical effort, education or travel support, and exposure to mitochondrial-disease research and trials when available.

Up to $20,000 in services from one or more UW Nathan Shock Center cores for pilot projects in the biology of aging. Available cores cover protein and metabolic phenotypes, invertebrate aging models, and explainable AI for aging.

Research traineeships in geroscience and the biology of aging. Postdoctoral applicants propose a two- or three-year training appointment and research topics with a participating faculty preceptor; predoctoral trainees must first be admitted to USC graduate study.

Rolling support for biology-of-aging pilot projects using multiple core services, single-service core vouchers, and mini-sabbaticals for hands-on technology training and collaboration at USC or the Buck Institute.

NIA-funded training positions for postdoctoral researchers pursuing basic aging biology and lifespan-intervention research, including somatic mutations, epigenetic change, oxidative damage, DNA repair, endocrine and immune biology, signaling, differentiation, and age-associated disease mechanisms.

Two-year fellowship for PhD candidates and postdoctoral fellows in Academy-affiliated laboratories who want to communicate geroscience and aging biology. Recipients receive a $5,000 stipend, Academy mentorship, and expenses-paid participation in selected Academy programs.

Usually five years of support for early-career researchers to lead innovative health-related research, including eligible mechanistic studies of aging biology and age-related disease.

Up to $30,000 in service-based support for ten-month projects exploring the basic biology of aging and metabolism through Wisconsin Nathan Shock Center cores, services, and platforms.

Up to $15,000 in Wisconsin Nathan Shock Center core services for six-month, sample-ready projects in basic aging biology, emphasizing metabolism, aging phenotypes, age-related vulnerability, and rapid generation of manuscript or grant-feasibility data.

Seven-year global prize competition challenging teams to develop and test therapies that restore muscle, cognitive, and immune function in older adults.